| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |